TREAT-NMD Services Ltd, the business arm of TREAT-NMD Alliance Ltd, a charity focused on neuromuscular disorders, and Aetion, Inc., the global leader in real-world evidence (RWE) technology and analytics, today announced a three-year global partnership that will see the organizations working on a number of projects to expedite the development of treatment solutions for people with rare neuromuscular diseases – e.g., spinal muscular atrophy (SMA), Duchenne muscular dystrophy, Charcot, and Becker muscular dystrophy. Accessing registries...